Europe hospital information system market was valued at $ 18,516.2 million in 2021 and will grow by 10.0% annually over 2021-2031, driven by the rising demand for efficient workflow and streamlined operations/data management, the increasing automation and digitalization across the healthcare industry, the growing adoption of cloud-based HIS, and the significant improvements in the healthcare infrastructure supported by increased funding from government and private sectors. Highlighted wit...
Asia Pacific hospital information system market will grow by 11.2% annually with a total addressable market cap of $289,027.1 million over 2022-2031, driven by the rising demand for efficient workflow and streamlined operations/data management, the increasing automation and digitalization across the healthcare industry, the growing adoption of cloud-based HIS, and the significant improvements in the healthcare infrastructure supported by increased funding from government and private secto...
Global Personal Mobility Devices Market will reach $20,923.2 million by 2031, growing by 6.7% annually over 2021-2031, driven by the aging population and surge in chronic diseases, increasing disability cases and accidents causing impairment of the limbs, increasing product development, rising purchasing power, and the favorable reimbursement policies. Highlighted with 60 tables and 70 figures, this 146-page report “Global Personal Mobility Devices Market 2021-2031 by Product (Wheelchai...
North America Personal Mobility Devices Market is projected to grow by 5.8% annually in the forecast period and reach $7,046.9 million by 2031, driven by the aging population and surge in chronic diseases, increasing disability cases and accidents causing impairment of the limbs, increasing product development, rising purchasing power, and the favorable reimbursement policies. Highlighted with 18 tables and 34 figures, this 84-page report “North America Personal Mobility Devices Market ...
Europe Personal Mobility Devices Market was valued at $3,519.5 million in 2021 and will grow by 6.1% annually over 2021-2031, driven by the aging population and surge in chronic diseases, increasing disability cases and accidents causing impairment of the limbs, increasing product development, rising purchasing power, and the favorable reimbursement policies. Highlighted with 25 tables and 38 figures, this 90-page report “Europe Personal Mobility Devices Market 2021-2031 by Product (Whe...
Asia Pacific Personal Mobility Devices Market will grow by 8.4% annually with a total addressable market cap of $38,844.0 million over 2022-2031, driven by the aging population and surge in chronic diseases, increasing disability cases and accidents causing impairment of the limbs, increasing product development, rising purchasing power, and the favorable reimbursement policies. Highlighted with 23 tables and 37 figures, this 90-page report “Asia Pacific Personal Mobility Devices Market...
Global pharmacovigilance and drug safety software market will reach $432.3 million by 2031, growing by 7.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 82 tables and 92 figure...
North America pharmacovigilance and drug safety software market is projected to grow by 6.7% annually in the forecast period and reach $158.6 million by 2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted wi...
Europe pharmacovigilance and drug safety software market was valued at $61.1 million in 2021 and will grow by 7.4% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 33 tables and 60...
Asia Pacific pharmacovigilance and drug safety software market will grow by 8.9% annually with a total addressable market cap of $817.5 million over 2022-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted w...
